dihexa injectable Peptide Therapy Dihexa | Revera

Aggressive agitation breaks peptide bonds and creates aggregates

This product is supplied exclusively for scientific, educational, and laboratory research purposes

Several lines of evidence point to upregulation of vascular endothelial growth factor receptor 2 (VEGFR2) signaling and modulation of the nitric oxide system [Huang et al., Vascular Pharmacology, 2015]

Although MELs promise as a carcinoma treatment modality has long been identified, its fast breakdown in circulation and unexpected cellular lysis activities provide substantial obstacles

Desvoyes B, Gutierrez C

GH/IGF-I axis and matrix adaptation of the musculotendinous tissue to exercise in humans